SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-077227
Filing Date
2022-03-16
Accepted
2022-03-16 16:06:00
Documents
13
Period of Report
2022-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d327212d8k.htm   iXBRL 8-K 34786
2 EX-99.1 d327212dex991.htm EX-99.1 101920
  Complete submission text file 0001193125-22-077227.txt   273284

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fixx-20220310.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20220310_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20220310_pre.xml EX-101.PRE 11279
7 EXTRACTED XBRL INSTANCE DOCUMENT d327212d8k_htm.xml XML 3344
Mailing Address ONE PATRIOTS PARK BEDFORD MA 01730
Business Address ONE PATRIOTS PARK BEDFORD MA 01730 781-301-7277
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 22744909
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences